| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |